Vipivotide tetraxetan

Research use only, not for human use.

Vipivotide tetraxetan is a high potent inhibitor of prostate-specific membrane antigen (PSMA)(Ki of 0.37 nM).

Vipivotide tetraxetan is a high potent inhibitor of prostate-specific membrane antigen (PSMA)(Ki of 0.37 nM).(In Vitro):Vipivotide tetraxetan demonstrated high radihigh inhibition potency, highly efficient internalization into LNCaP cells and olytic stability for at least 72 h.(In Vivo):The small-animal PET measurements showed high tumor-to-background contrasts as early as 1 h after injection of Vipivotide tetraxetan.?Organ distribution revealed specific uptake in LNCaP tumors and in the kidneys 1 h after injection of Vipivotide tetraxetan.

PSMA-617

Others

Other Targets

——

——

——

1702967-37-0

1042.2

C49H71N9O16

>98% (HPLC)

——

OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H]1CC[C@H](CNC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)CC1)C(O)=O)C(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years